Shopping Cart
- Remove All
- Your shopping cart is currently empty
Altretamine (ENT-50852) is an alkylating agent with antineoplastic activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | $30 | In Stock | |
100 mg | $40 | In Stock | |
200 mg | $70 | In Stock | |
500 mg | $158 | In Stock | |
1 g | $237 | In Stock | |
1 mL x 10 mM (in DMSO) | $44 | In Stock |
Description | Altretamine (ENT-50852) is an alkylating agent with antineoplastic activity. |
In vitro | In elevated plus-maze and light/dark tests in BALB/c mice, Flumazenil (1 mg/kg) exhibited strong anxiolytic effects. Flumazenil (3 mg/kg) prevented alterations induced by chronic ethanol withdrawal in mice, such as decreased open arm time and percentage of open arm entries. In rats, Flumazenil (10 mg/kg) effectively counteracted the reductive effects of tetrahydropregnanolone. Flumazenil (5-20 mg/kg) antagonized the effects of diazepam in mice without affecting the anticonvulsant and adverse responses to GYKI52466. In the MES model, as opposed to the PTZ test, Flumazenil slightly reduced the anticonvulsant activity of NBQX. Flumazenil binds to central benzodiazepine (BZD) receptors, thereby antagonizing or reversing the neurophysiological effects of BZD depressants and agonists. It reverses the depressant sedative responses caused by the combined use of BZD and other drugs but is not effective for cyclic antidepressant overdose. |
Alias | WR-95704, RB-1515, NSC13875, Hexamethylmelamine, ENT-50852 |
Molecular Weight | 210.28 |
Formula | C9H18N6 |
Cas No. | 645-05-6 |
Smiles | N(C)(C)C=1N=C(N(C)C)N=C(N(C)C)N1 |
Relative Density. | 1.0441 g/cm3 (Estimated) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 8.4 mg/mL (39.95 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 8 mg/mL (38 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
Ethanol/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.